|
1
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu J, Jung C, Xu J, Wang H, Deng S,
Bernad L, Arenas-Huertero C and Chua NH: Genome-wide analysis
uncovers regulation of long intergenic noncoding RNAs in
Arabidopsis. Plant Cell. 24:4333–4345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF, et al: The lncRNA H19
promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhan A and Mandal SS: LncRNA HOTAIR: A
master regulator of chromatin dynamics and cancer. Biochim Biophys
Acta. 1856:151–164. 2015.PubMed/NCBI
|
|
7
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Xie P and Ruan WH: Overexpression of
lncRNA UCA1 promotes osteosarcoma progression and correlates with
poor prognosis. J Bone Oncol. 5:80–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun XH, Yang LB, Geng XL, Wang R and Zhang
ZC: Increased expression of lncRNA HULC indicates a poor prognosis
and promotes cell metastasis in osteosarcoma. Int J Clin Exp
Pathol. 8:2994–3000. 2015.PubMed/NCBI
|
|
12
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu J, Cheng G, Zhang C, Zheng Y, Xu H,
Yang H and Hua L: Long noncoding RNA LINC01296 is associated with
poor prognosis in prostate cancer and promotes cancer-cell
proliferation and metastasis. Onco Targets Ther. 10:1843–1852.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu JJ and Yan JB: Long non-coding RNA
LINC01296 is a potential prognostic biomarker in patients with
colorectal cancer. Tumor Biol. 36:7175–7183. 2015. View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song LN: Effects of retinoic acid and
dexamethasone on proliferation, differentiation, and glucocorticoid
receptor expression in cultured human osteosarcoma cells. Oncol
Res. 6:111–118. 1994.PubMed/NCBI
|
|
17
|
Jiang C, Fang X, Zhang H, Wang X, Li M,
Jiang W, Tian F, Zhu L and Bian Z: AMD3100 combined with triptolide
inhibit proliferation, invasion and metastasis and induce apoptosis
of human U2OS osteosarcoma cells. Biomed Pharmacother. 86:677–685.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wen J, Wang L, Zhang M, Xie D and Sun L:
Repression of telomerase activity during in vitro differentiation
of osteosarcoma cells. Cancer Invest. 20:38–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seitz AK, Christensen LL, Christensen E,
Faarkrog K, Ostenfeld MS, Hedegaard H, Nordentoft I, Nielsen MM,
Palmfeldt J, Thomson M, et al: Profiling of long non-coding RNAs
identifies LINC00958 and LINC01296 as candidate oncogenes in
bladder cancer. Sci Rep. 7:3952017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee Y, Dominy JE, Choi YJ, Jurczak M,
Tolliday N, Camporez JP, Chim H, Lim JH, Ruan HB, Yang X, et al:
Cyclin D1-Cdk4 controls glucose metabolism independently of cell
cycle progression. Nature. 510:547–551. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin QH, Yin ZQ, Li Y, Wang BG and Zhang
MF: Long intergenic noncoding RNA 01296 aggravates gastric cancer
cells progress through miR-122/MMP-9. Biomed Pharmacother.
97:450–457. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang K, Zhang M, Wang C and Ning X: Long
noncoding RNA LINC01296 harbors miR-21a to regulate colon carcinoma
proliferation and invasion. Oncol Res. Apr 19–2018.(Epub ahead of
print). View Article : Google Scholar
|
|
23
|
Zhang D, Li H, Xie J, Jiang D, Cao L, Yang
X, Xue P and Jiang X: Long noncoding RNA LINC01296 promotes tumor
growth and progression by sponging miR-5095 in human
cholangiocarcinoma. Int J Oncol. 52:1777–1786. 2018.PubMed/NCBI
|
|
24
|
Qie S and Diehl JA: Cyclin D1, cancer
progression, and opportunities in cancer treatment. J Mol Med
(Berl). 94:1313–1326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Williams GT and Pickard MR: Long
non-coding RNAs: New opportunities and old challenges in cancer
therapy. Transl Cancer Res. 5 Suppl:S564–S566. 2016. View Article : Google Scholar
|
|
27
|
Li Han C and Chen Y: Small and long
non-coding RNAs: Novel targets in perspective cancer therapy. Curr
Genomics. 16:319–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li S, Sun W, Wang H, Zuo D, Hua Y and Cai
Z: Research progress on the multidrug resistance mechanisms of
osteosarcoma chemotherapy and reversal. Tumor Biol. 36:1329–1338.
2015. View Article : Google Scholar
|
